Therefore, miR‐34a expression was higher in CHD patients than controls; (2) MiR‐34a inhibited the differentiation of vascular smooth muscle cells and promoted endothelial dysfunction by downregulation of Bcl2, which were positively related to the occurrence of CHD.29, 30, 31, 32. Here, BCL2 is linked to endothelial dysfunction.